Inherited human complement C5 deficiency. Nonsense mutations in exons 1 (Gln1 to Stop) and 36 (Arg1458 to Stop) and
X Wang1, D T Fleischer, W T Whitehead
1Department of Pediatrics, Washington University School of Medicine, St. Louis, MO 63110, USA.
Insights
Two novel nonsense mutations in the C5 gene explain hereditary complement component 5 deficiency in African-American families. These genetic defects lead to compound heterozygosity in affected individuals.
Area of Science:
- Immunology
- Genetics
- Molecular Biology
Background:
- Hereditary C5 deficiency (C5D) is a rare genetic disorder affecting the complement system.
- Previous reports identified C5D in various ethnic groups, but the underlying molecular genetic defects remained largely unknown.
- Understanding the genetic basis of C5D is crucial for diagnosing and potentially treating related immune deficiencies.
Purpose of the Study:
- To investigate the molecular genetic basis of C5 deficiency in African-American families.
- To identify specific mutations in the C5 gene responsible for C5D in this population.
Main Methods:
- Sequencing of C5 gene exons and intron/exon boundaries in three C5-deficient African-American families.
- Utilized allele-specific PCR and sequence analyses to confirm mutation presence and inheritance patterns.
- Screened European and Caucasian-American C5D individuals for the identified mutations.
Main Results:
- Identified two distinct nonsense mutations in the C5 gene: one in exon 1 (C84AG to TAG) and another in exon 36 (C4521GA to TGA).
- The exon 1 mutation affects the C5 beta-chain, while the exon 36 mutation impacts the C5 alpha-chain.
- These mutations were found to be present in compound heterozygous states in all studied African-American C5D families and were absent in European/Caucasian-American C5D individuals.
Conclusions:
- Hereditary C5 deficiency results from diverse molecular genetic defects.
- Two specific nonsense mutations in exons 1 and 36 of the C5 gene partially explain C5 deficiency in the African-American population.
- Compound heterozygosity for these mutations is a common genetic mechanism underlying C5D in these families.
Abstract:
Hereditary C5 deficiency has been reported in several families of different ethnic backgrounds and from different geographic regions, but the molecular genetic defect causing C5 deficiency has not been delineated in any of them. To examine the molecular basis of C5 deficiency in the African-American population, the exons and intron/exon boundaries of the C5 structural genes from three C5-deficient (C5D) African-American families were sequenced, revealing two nonsense mutations. The nonsense mutations are located in exon 1 (C84AG to TAG) in two of the C5D families (Rhode Island and North Carolina) and in exon 36 (C4521GA to TGA) in the third C5D family (New York). The exon 1 and 36 mutations are contained in codons that encode the first amino acid of the C5 beta-chain (Gln1 to Stop) and residue 1458 in the alpha-chain (Arg1458 to Stop), respectively. Allele-specific PCR and sequence analyses demonstrated that the exon 1 mutation is present in only one of the C5 null genes in both the Rhode Island and North Carolina families, and the exon 36 mutation is contained in only one C5 null gene in the New York family. Neither of the nonsense mutations was found in the European or Caucasian-American C5D individuals examined. Collectively, these data indicate that: 1) C5 deficiency is caused by several different molecular genetic defects, 2) C5 deficiency in the African-American population can be explained in part by two distinct nonsense mutations in exons 1 and 36, and 3) compound heterozygosity exists in all of the reported African-American C5D families.
More Related Videos
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
03:45Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Related Concept Videos
Genetic Lingo
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Incomplete Dominance
Lethal Alleles
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Complementation Tests
Organisms heterozygous for different mutations are crossed pairwise in all combinations. If present on different genes, the mutations can complement each other by providing the missing...
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
